Top Markets
#1 Helium Helium +45.70%
#2 TENDIES TENDIES +42.44%
#3 Pons Pons +36.20%
#4 UnifAI Network UnifAI Network +19.28%
#5 Seeker Seeker +18.90%
#6 Songbird Songbird +12.44%
#7 OSK OSK +10.10%
#8 Bounce Bounce +9.81%
#9 DAPPOS DAPPOS +9.74%
#10 Lista DAO Lista DAO +8.75%
Coin of the day
Helium Helium
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Shanghai Haohai Biological Technology Co., Ltd. Shanghai Haohai Biological Technology Co., Ltd.

Shanghai Haohai Biological Technology Co., Ltd.

688366
Rangering i aksjer #10462
Shanghai Haohai Biological Technology Co., Ltd. is a global enterprise... Shanghai Haohai Biological Technology Co., Ltd. is a global enterprise specializing in the research, development, manufacturing, and distribution of advanced biomedical materials. Its operations span Mainland China, the United States, the United Kingdom, and various international markets. The company's extensive product portfolio serves multiple medical fields. For ophthalmology, offerings include intraocular lenses, ophthalmic viscoelastic devices, specialized orthokeratology and phakic refractive lenses, eye drops, injectors, and surgical scalpels. In orthopedics, they provide sodium hyaluronate injections and medical chitosan. Their wound care segment features recombinant human epidermal growth factor, effective in treating a broad spectrum of injuries, including burns, residual wounds, donor site trauma, post-traumatic wounds, and both acute and chronic ulcerations. Anti-adhesion solutions are offered in the form of medical sodium hyaluronate gel and medical chitosan, while hemostatic products include collagen sponges and porcine fibrin sealants. Within medical aesthetics, Shanghai Haohai produces a diverse range of hyaluronic acid (HA) dermal fillers: Matrifill, a first-generation mono-phase injectable gel; Janlane, a second-generation filler engineered for dynamic applications; and Hyalumatrix, a third-generation product designed for precise aesthetic enhancements. This division also supplies radio frequency devices and laser equipment. Beyond its core product offerings, the company actively pursues research and development in biological engineering and pharmaceutical innovations. It also provides related technology transfer and consultation services, alongside engaging in investment and trading activities. Originally established in 2007 as Haohai Limited, the company adopted its current name, Shanghai Haohai Biological Technology Co., Ltd., in 2010 and is headquartered in Shanghai, China.
Aksjekurs
$4.39
Sist synkronisert: 2026-08-28
Markedsverdi
$835.72M
Endring (1 dag)
0.33%
Endring (1 år)
-42.81%
Land
CN
Handel Shanghai Haohai Biological Technology Co., Ltd. (688366)

Kategori

Healthcare
Aksjeprishistorikk for Shanghai Haohai Biological Technology Co., Ltd. (688366)
Høyeste sluttskurs: $4.58 den 2026-08-01

Laveste sluttskurs: $12.22 den 2019-10-01
Aksjeprishistorikk for Shanghai Haohai Biological Technology Co., Ltd. fra 2019 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -7.96%
2025 -24.84%
2024 -17.25%
2023 18.20%
2022 -39.68%
2021 38.45%
2020 20.76%
2019 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH